Drug Report History #279452
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v2-FR | Version v2-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-03-02 | 2026-03-02 |
| Drug Identification Number | 01926691 | 01926691 |
| Brand name | CALCIMAR | CALCIMAR |
| Common or Proper name | CALCITONIN | CALCITONIN |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | CALCITONIN | CALCITONIN |
| Strength(s) | 200UNIT | 200UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
| Packaging size | 1 | 1 |
| Anatomical Therapeutical Chemical (ATC) code | H05BA | H05BA |
| Anatomical Therapeutical Chemical (ATC) description | ANTI-PARATHYROID HORMONES | ANTI-PARATHYROID HORMONES |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | 2026-08-30 | 2026-08-30 |
| Actual discontinuation date | ||
| Remaining supply date | ||
| Discontinuation status | To be discontinued | To be discontinued |
| Discontinuation decision reversal | No | No |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Third Party Manufacturing Site Operational changes – Calcimar no longer manufactured | Third Party Manufacturing Site Operational changes – Calcimar no longer manufactured |
| Health Canada comments |